Objective: Percutaneous injection of ethanol was evaluated in terminal
ly ill cancer patients with painful osteolytic bone metastases treated
previously without success by radiation or chemotherapy and conventio
nal pain therapy. Methods and Materials: Twenty-five patients with 27
bone metastases in various locations underwent one to three instillati
ons of 3-25 mi ethanol (95%) under CT guidance, which allowed precise
needle positioning and control of the diffusion of alcohol thus minimi
zing the complications. Results: Within 24 to 48 h 74% of the cases ex
perienced a reduction of analgesic needs. Conclusion: Percutaneous eth
anol injection under CT guidance is useful in reducing pain and in imp
roving the quality of life of patients with advanced stages of cancer
and painful bone metastases.